The implication of aberrant NRF2 activation in management of female cancers

Mankgopo Kgatle1,2,3, Saidon Mbambara1,2,4, Olalekan Fadebi1,2

  • 1Nuclear Medicine Research Infrastructure, Department of Basic and Translational Research, Pretoria, South Africa.

Frontiers in Oncology
|December 3, 2025
PubMed

Insights

Overactivation of Nuclear factor erythroid 2-related factor 2 (NRF2) promotes cancer cell survival and treatment resistance in female malignancies. Targeting NRF2 offers a promising strategy for improving precision oncology outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor regulating antioxidant genes.
  • NRF2 plays a dual role in cancer: tumor suppressor in normal cells and oncogene in established tumors.
  • NRF2 overactivation in the tumor microenvironment contributes to inflammation-induced oxidative stress and cancer progression.

Purpose of the Study:

  • To provide a comprehensive overview of NRF2 activation in female malignancies.
  • To explore the association between NRF2 and chemoresistance in these cancers.
  • To highlight challenges and opportunities for developing targeted NRF2 therapies.

Main Methods:

  • Literature review of NRF2's role in cervical, endometrial, ovarian, vaginal, vulvar, and breast cancers.
  • Analysis of NRF2's transcriptional alterations and its impact on treatment efficacy.
  • Examination of NRF2's context-dependent functions in carcinogenesis and tumor progression.

Main Results:

  • NRF2 overactivation enhances tumor cell survival, proliferation, and treatment resistance.
  • Persistent NRF2 activation acts as an oncogene in established tumors.
  • NRF2's role varies depending on its activation status and cellular context.

Conclusions:

  • Understanding NRF2's role is crucial for improving cancer management and prognosis.
  • Targeted therapies against NRF2 present a promising avenue for precision oncology.
  • Further research into NRF2 alterations can lead to more effective cancer treatments.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K